Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 46 | 0 | 11 | 0 | €116.25 | €149.74 | 28.805% |
| Alnylam Pharmace. | 45 | 0 | 7 | 0 | €264.00 | €275.25 | 4.261% |
| Tenet Healthcare | 42 | 0 | 4 | 0 | €149.00 | €154.91 | 3.968% |
| Acadia Pharmaceuticals | 35 | 1 | 7 | 0 | €14.13 | €29.92 | 111.790% |
| Jazz Pharmaceuticals plc | 30 | 0 | 6 | 0 | €104.15 | €183.41 | 76.106% |
| United Therapeutics | 27 | 1 | 5 | 1 | €325.20 | €341.51 | 5.015% |
| Ultragenyx Pharmaceutical Inc. | 25 | 1 | 4 | 0 | €51.00 | €84.74 | 66.165% |
| Icon plc | 24 | 0 | 0 | 0 | €289.40 | €326.21 | 12.720% |
| Halozyme Therapeutics Inc. | 23 | 0 | 5 | 0 | €57.88 | €56.00 | -3.252% |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 2 | 1 | €42.80 | €56.72 | 32.527% |
| Merit Medical Systems | 22 | 0 | 3 | 0 | €86.00 | €90.45 | 5.179% |
| Exelixis Inc. | 21 | 0 | 3 | 0 | €23.23 | €26.01 | 11.952% |
| Iovance Biotherapeutics Inc. | 20 | 2 | 1 | 0 | €10.28 | €26.24 | 155.214% |
| Molina Healthcare | 17 | 1 | 2 | 0 | €316.40 | €370.26 | 17.023% |
| Insulet Corp. | 16 | 0 | 2 | 0 | €184.00 | €215.54 | 17.140% |
| Arrowhead Pharmaceuticals Inc. | 18 | 2 | 1 | 0 | €22.15 | €55.13 | 148.912% |
| Medpace Holdings Inc | 16 | 0 | 0 | 0 | €330.50 | €418.12 | 26.512% |
| Repligen Corp. | 15 | 0 | 4 | 0 | €130.50 | €178.01 | 36.408% |
| Alkermes plc | 17 | 2 | 0 | 0 | €25.40 | €35.01 | 37.847% |
| Charles River Labs Intl | 13 | 0 | 2 | 0 | €177.20 | €247.61 | 39.733% |
| CONMED Corp. | 14 | 2 | 3 | 0 | €63.00 | €98.42 | 56.219% |
| LivaNova plc | 12 | 0 | 1 | 0 | €42.00 | €66.49 | 58.314% |
| QIAGEN NV | 12 | 0 | 1 | 0 | €40.47 | €47.52 | 17.415% |
| Amedisys Inc. | 11 | 0 | 0 | 0 | €87.00 | €92.26 | 6.046% |
| Bio-Techne Corp. | 9 | 0 | 1 | 0 | €67.50 | €75.80 | 12.301% |